(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

122019016628

Em AnáliseUtility ModelPCT · US2010050005

Application data

Number

122019016628

Type

Utility Model

Filing

09/23/2010

Publication

-

PCT

US2010050005

Progress at the INPI

  1. Filing09/23/10
  2. Publication
  3. Examination
  4. Allowance12/29/20
  5. Grant02/23/21
  6. In force09/23/25

The patent was granted on 02/23/2021 and is in force until 09/23/2025. Until then, no one may make, use or sell the invention in Brazil without the owner's authorisation.

Protection valid until:09/23/2025

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 06/21/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

AMARIN CORPORATION PLC

IE

AMARIN PHARMACEUTICALS IRELAND LIMITED

IE

Inventors

J. R. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

61/245,086 · 09/23/2009

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Transferência deferida

#25.1

06/21/2022

RPI 2685

Alteração de sede deferida

#25.7

06/14/2022

RPI 2684

16.3

Prazo de Validade: 20 (vinte) anos contados a partir de 23/09/2010, observadas as condições legais. Patente concedida conforme ADI 5.529/DF, que determina a alteração do prazo de concessão

07/27/2021

RPI 2638

Concessão da patente

#16.1

10 (dez) anos contados a partir de 23/02/2021, observadas as condições legais

02/23/2021

RPI 2616

Deferimento

#9.1

12/29/2020

RPI 2608

Conhecimento de parecer técnico

#7.1

08/11/2020

RPI 2588

Notificação de pedido dividido

#2.4

Dividido do PCT 11 2012 006692-7

09/24/2019

RPI 2542

Requerimento de pedido de patente

#2.10

Número de Protocolo '870190077517' em 12/08/2019 10:59 (WB)

08/20/2019

RPI 2537

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.